Nexalin Technology Inc Warrant
NXLIW
NXLIW was delisted on the 19th of September, 2025.
8 hedge funds and large institutions have $143K invested in Nexalin Technology Inc Warrant in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$65K |
| 2 |
EAM
Empery Asset Management
New York
|
+$24K |
| 3 |
ACM
Altium Capital Management
New York
|
+$21K |
| 4 |
CS
Clear Street
New York
|
+$16K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$8.15K |
Top Sellers
NXLIW Hedge Fund Activity: Q3 2022 in Review
8 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology Inc Warrant (NXLIW) for Q3 2022, worth a combined $143K.
Buyers outnumbered sellers: 8 funds opened new NXLIW positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $65K.
- 8 institutional investors held Nexalin Technology Inc Warrant (NXLIW) as of Q3 2022, up from 0 in Q2 2022.
- Funds reported $143K of Nexalin Technology Inc Warrant stock for Q3 2022.
- 8 funds opened new Nexalin Technology Inc Warrant positions in Q3 2022 and 0 closed out, a net change of +8 holders.
- The largest Nexalin Technology Inc Warrant buyer in Q3 2022 was Armistice Capital, an estimated $65K added.
Based on aggregated 13F filings for Q3 2022.